Camp4 Therapeutics (CAMP) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.17, -8.12% vs the prior close of $3.45.
- Volume 92.40K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CAMP slides 8.1% to $3.17, a 1-month low. Closed at $3.17, -8.12% vs the prior close of $3.45. Day range $3.17–$3.45, opened at $3.45.
CAMP daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CAMP slides 8.1% to $3.17, a 1-month low
- Closed at $3.17, -8.12% vs the prior close of $3.45. Day range $3.17–$3.45, opened at $3.45.
- Volume was 92.40K shares, 0.3x its 50-day average of 295.82K — lighter than usual.
- Price is -23.1% vs its 50-day average ($4.12) and -27.1% vs its 200-day average ($4.35).
- 52-week range $2.86–$7.75; today's close sits at 6% of that range, 59.1% below the 52-week high.
Oct 15, 2026 — CAMP rises 0.6% to $3.45
- Closed at $3.45, +0.58% vs the prior close of $3.43. Day range $3.43–$3.54, opened at $3.46.
- Volume was 56.30K shares, 0.2x its 50-day average of 296.42K — lighter than usual.
- Price is -16.8% vs its 50-day average ($4.15) and -20.9% vs its 200-day average ($4.36).
- 52-week range $2.86–$7.75; today's close sits at 12% of that range, 55.5% below the 52-week high.
Oct 14, 2026 — CAMP ends flat (+0.0%) to $3.43, 3 down days in a row
- Closed at $3.43, +0.00% vs the prior close of $3.43. Day range $3.17–$3.44, opened at $3.33.
- Volume was 155.70K shares, 0.5x its 50-day average of 297.51K — lighter than usual.
- Price is -17.5% vs its 50-day average ($4.16) and -21.6% vs its 200-day average ($4.38).
- 52-week range $2.86–$7.75; today's close sits at 12% of that range, 55.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CAMP slides 6.3% to $3.43, a 1-month low
- Closed at $3.43, -6.28% vs the prior close of $3.66. Day range $3.38–$3.80, opened at $3.66.
- Volume was 88.50K shares, 0.3x its 50-day average of 301.66K — lighter than usual.
- Price is -17.8% vs its 50-day average ($4.17) and -21.8% vs its 200-day average ($4.39).
- 52-week range $2.86–$7.75; today's close sits at 12% of that range, 55.7% below the 52-week high.
Oct 12, 2026 — CAMP dips 2.9% to $3.66, a 1-month low
- Closed at $3.66, -2.92% vs the prior close of $3.77. Day range $3.65–$3.76, opened at $3.71.
- Volume was 36.10K shares, 0.1x its 50-day average of 302.77K — lighter than usual.
- Price is -12.6% vs its 50-day average ($4.19) and -16.8% vs its 200-day average ($4.40).
- 52-week range $2.86–$7.75; today's close sits at 16% of that range, 52.8% below the 52-week high.
Oct 9, 2026 — CAMP rises 1.9% to $3.77
- Closed at $3.77, +1.89% vs the prior close of $3.70. Day range $3.62–$3.87, opened at $3.70.
- Volume was 72.10K shares, 0.2x its 50-day average of 302.29K — lighter than usual.
- Price is -9.9% vs its 50-day average ($4.18) and -14.5% vs its 200-day average ($4.41).
- 52-week range $2.86–$7.75; today's close sits at 19% of that range, 51.4% below the 52-week high.
Oct 8, 2026 — CAMP slides 3.6% to $3.70, a 1-month low, 3 down days in a row
- Closed at $3.70, -3.65% vs the prior close of $3.84. Day range $3.51–$3.80, opened at $3.80.
- Volume was 278.30K shares, 0.9x its 50-day average of 298.58K.
- Price is -11.5% vs its 50-day average ($4.18) and -16.3% vs its 200-day average ($4.42).
- 52-week range $2.86–$7.75; today's close sits at 17% of that range, 52.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — CAMP slides 3.0% to $3.84
- Closed at $3.84, -3.03% vs the prior close of $3.96. Day range $3.84–$4.12, opened at $3.85.
- Volume was 148.50K shares, 0.5x its 50-day average of 297.59K — lighter than usual.
- Price is -7.9% vs its 50-day average ($4.17) and -13.4% vs its 200-day average ($4.44).
- 52-week range $2.86–$7.75; today's close sits at 20% of that range, 50.5% below the 52-week high.
Oct 6, 2026 — CAMP dips 1.2% to $3.96 on 4.4x normal volume
- Closed at $3.96, -1.25% vs the prior close of $4.01. Day range $3.75–$4.03, opened at $4.03.
- Volume was 1.23M shares, 4.4x its 50-day average of 279.72K — unusually heavy trading.
- Price is -4.8% vs its 50-day average ($4.16) and -11.0% vs its 200-day average ($4.45).
- 52-week range $2.86–$7.75; today's close sits at 22% of that range, 48.9% below the 52-week high.
Oct 5, 2026 — CAMP ends flat (+0.3%) to $4.01
- Closed at $4.01, +0.25% vs the prior close of $4.00. Day range $3.74–$4.09, opened at $4.00.
- Volume was 381.20K shares, 1.4x its 50-day average of 275.48K.
- Price is -3.4% vs its 50-day average ($4.15) and -10.2% vs its 200-day average ($4.46).
- 52-week range $2.86–$7.75; today's close sits at 24% of that range, 48.3% below the 52-week high.
Oct 2, 2026 — CAMP jumps 4.2% to $4.00
- Closed at $4.00, +4.17% vs the prior close of $3.84. Day range $3.69–$4.05, opened at $3.90.
- Volume was 368.00K shares, 1.4x its 50-day average of 271.77K.
- Price is -3.2% vs its 50-day average ($4.13) and -10.7% vs its 200-day average ($4.48).
- 52-week range $2.85–$7.75; today's close sits at 23% of that range, 48.4% below the 52-week high.
CAMP latest news & SEC filings
Every SEC filing by or about CAMP in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gold Kelly bought 10,000 shares at $3.96 (≈$39.60K) on Aug 31, 2026
- Gold Kelly bought 10,000 shares at $3.96 (≈$39.60K) on Aug 31, 2026
- Gold Kelly bought 10,000 shares at $3.96 (≈$39.60K) on Aug 31, 2026
- Gold Kelly bought 10,000 shares at $3.96 (≈$39.60K) on Aug 31, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 31, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 31, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schwab Andrew J. sold 400,000 shares at $4.04 (≈$1.62M) on Aug 27, 2026
- Schwab Andrew J. sold 400,000 shares at $4.04 (≈$1.62M) on Aug 27, 2026
- Schwab Andrew J. sold 400,000 shares at $4.04 (≈$1.62M) on Aug 27, 2026
- Schwab Andrew J. sold 400,000 shares at $4.04 (≈$1.62M) on Aug 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 26, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schwab Andrew J. sold 10 shares at $4.50 (≈$45) on Aug 24, 2026
- Schwab Andrew J. sold 10 shares at $4.50 (≈$45) on Aug 24, 2026
- Schwab Andrew J. sold 10 shares at $4.50 (≈$45) on Aug 24, 2026
- Schwab Andrew J. sold 10 shares at $4.50 (≈$45) on Aug 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Schwab Andrew J. sold 32,018 shares at $4.50 (≈$144.08K) on Aug 21, 2026
- Schwab Andrew J. sold 32,018 shares at $4.50 (≈$144.08K) on Aug 21, 2026
- Schwab Andrew J. sold 32,018 shares at $4.50 (≈$144.08K) on Aug 21, 2026
- Schwab Andrew J. sold 32,018 shares at $4.50 (≈$144.08K) on Aug 21, 2026
- Schwab Andrew J. sold 114,700 shares at $4.54 (≈$520.74K) on Aug 20, 2026
- Schwab Andrew J. sold 114,700 shares at $4.54 (≈$520.74K) on Aug 20, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tardiff Daniel sold 1,738 shares at $4.76 (≈$8.27K) on Aug 19, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 19, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.78M (prior year $1.50M) (+18.8% vs Jun 30, 2025)
- Net income: -$33.53M (prior year -$12.59M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.58 (prior year -$0.62) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 12, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 10, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CAMP
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Nov 6, 2025, Aug 14, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.08% (largest 10.4%). That is a volatile stock.
- Liquidity: about 280.65K shares (≈$889.66K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.17 vs a range of $2.86–$7.75 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Kelly Gold bought 10,000 shares on Aug 31, 2026.
- Latest filings: 8-K Sep 28, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 62.75M shares outstanding (Aug 12, 2026), +211.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CAMP market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.45 | 3.45 | 3.17 | 3.17 | 92.40K |
| Oct 15, 2026 | 3.46 | 3.54 | 3.43 | 3.45 | 56.30K |
| Oct 14, 2026 | 3.33 | 3.44 | 3.17 | 3.43 | 155.70K |
| Oct 13, 2026 | 3.66 | 3.80 | 3.38 | 3.43 | 88.50K |
| Oct 12, 2026 | 3.71 | 3.76 | 3.65 | 3.66 | 36.10K |
| Oct 9, 2026 | 3.70 | 3.87 | 3.62 | 3.77 | 72.10K |
| Oct 8, 2026 | 3.80 | 3.80 | 3.51 | 3.70 | 278.30K |
| Oct 7, 2026 | 3.85 | 4.12 | 3.84 | 3.84 | 148.50K |
| Oct 6, 2026 | 4.03 | 4.03 | 3.75 | 3.96 | 1.23M |
| Oct 5, 2026 | 4.00 | 4.09 | 3.74 | 4.01 | 381.20K |
| Oct 2, 2026 | 3.90 | 4.05 | 3.69 | 4.00 | 368.00K |
| Oct 1, 2026 | 3.99 | 4.15 | 3.76 | 3.84 | 994.70K |
| Sep 30, 2026 | 3.96 | 4.09 | 3.86 | 4.04 | 170.70K |
| Sep 29, 2026 | 3.87 | 4.02 | 3.81 | 3.91 | 172.50K |
| Sep 28, 2026 | 3.86 | 3.95 | 3.73 | 3.85 | 116.90K |
| Sep 25, 2026 | 3.83 | 4.06 | 3.72 | 3.92 | 476.90K |
| Sep 24, 2026 | 3.78 | 3.94 | 3.67 | 3.84 | 130.30K |
| Sep 23, 2026 | 4.13 | 4.27 | 3.65 | 3.72 | 192.70K |
| Sep 22, 2026 | 4.21 | 4.24 | 3.86 | 4.15 | 161.20K |
| Sep 21, 2026 | 4.27 | 4.32 | 4.10 | 4.17 | 289.50K |
About Camp4 Therapeutics
Camp4 Therapeutics (CAMP) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WATERTOWN, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1736730.
CAMP board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Steven H Holtzman | Director | Jun 12, 2026 |
| Michael F Maclean | Director | Apr 3, 2026 |
| Josh Mandel-Brehm | Chief Executive Officer | Aug 5, 2026 |
| Amir Nashat | Director | Jun 12, 2026 |
| Andrew J. Schwab | Director | Aug 31, 2026 |
| Murray Stewart | Director | Jun 12, 2026 |
| Douglas E Williams | Director | Jun 12, 2026 |
| Richard A Young | Director | Aug 5, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kelly Gold | Chief Financial Officer | Sep 2, 2026 |
| Josh Mandel-Brehm | Chief Executive Officer | Aug 5, 2026 |
| Yuri Maricich | Chief Medical Officer | Aug 5, 2026 |
| Daniel Tardiff | Chief Scientific Officer | Aug 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Kelly Gold | Buy | 10,000 | $3.96 |
| Aug 31, 2026 | Kelly Gold | Buy | 10,000 | $3.96 |
| Aug 31, 2026 | Kelly Gold | Buy | 10,000 | $3.96 |
| Aug 31, 2026 | Kelly Gold | Buy | 10,000 | $3.96 |
| Aug 27, 2026 | Andrew J. Schwab | Sale | 400,000 | $4.04 |
| Aug 27, 2026 | Andrew J. Schwab | Sale | 400,000 | $4.04 |
| Aug 27, 2026 | Andrew J. Schwab | Sale | 400,000 | $4.04 |
| Aug 27, 2026 | Andrew J. Schwab | Sale | 400,000 | $4.04 |
| Aug 24, 2026 | Andrew J. Schwab | Sale | 10 | $4.50 |
| Aug 24, 2026 | Andrew J. Schwab | Sale | 10 | $4.50 |
| Aug 24, 2026 | Andrew J. Schwab | Sale | 10 | $4.50 |
| Aug 24, 2026 | Andrew J. Schwab | Sale | 10 | $4.50 |
| Aug 21, 2026 | Andrew J. Schwab | Sale | 32,018 | $4.50 |
| Aug 21, 2026 | Andrew J. Schwab | Sale | 32,018 | $4.50 |
| Aug 21, 2026 | Andrew J. Schwab | Sale | 32,018 | $4.50 |
CAMP financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.50M | $-80.40M | -2.65 | $-29.55M |
| Dec 31, 2024 | $652.00K | $-51.79M | -11.04 | $-45.56M |
| Dec 31, 2023 | $350.00K | $-49.29M | -124.80 | $-44.16M |
Latest balance sheet: total assets $93.43M, total liabilities $94.12M, cash $86.40M (as of Jun 30, 2026).
CAMP earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $4.50 |
| May 7, 2026 | 8-K Item 2.02 (results) | $4.34 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $4.45 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $1.55 |
| May 13, 2025 | 8-K Item 2.02 (results) | $2.02 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $4.42 |
| Nov 21, 2024 | 8-K Item 2.02 (results) | $5.78 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CAMP
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.